Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect

Recruiting now · Not applicable

Conditions studied: Atrial Septal Defect, Successful Device Closure

In brief

Background: Three-dimensional echocardiographic image for atrial septal defect (ASD) is useful for evaluation of defect size and shape. The investigators suggested optimal device size using three-dimensional transesophageal echocardiographic image and our formula in previous study. Purpose: In this study, the investigators seek to predict the correct device size and confirm the accuracy of the formula that we made before device closure in ASD patients.

Key facts

Study ID

NCT02097758

Run by

Asan Medical Center

People needed

100

Starts

2014-03-01

Expected to finish

2026-12-01

Last updated by the study team

2025-02-07

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥18 year-old
• Susceptible indication for atrial septal defect closure
• Potential candidate for device closure

You may not qualify if…

• Poor candidate for device closure: multiple ASDs, ect
• Other heart disease requiring open heart surgery

Where it is running

• Asan Medical Center — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.